Screening for late-onset Pompe disease in Finland
Johanna Palmio, Bjarne Udd(Tampere University Hospital), Mari Auranen(University of Helsinki), Sari Kiuru‐Enari(Helsinki University Hospital), Mervi Löfberg(Helsinki University Hospital), Olaf A. Bodamer(Broad Institute)
Cited by 29
Related Papers
Patient-Customized Oligonucleotide Therapy for a Rare Genetic Disease
|New England Journal of Medicine|2019|823
Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy
|European Journal of Pediatrics|2007|535
FGF-21 as a biomarker for muscle-manifesting mitochondrial respiratory chain deficiencies: a diagnostic study
|The Lancet Neurology|2011|420
Effective treatment of mitochondrial myopathy by nicotinamide riboside, a vitamin B3
|EMBO Molecular Medicine|2014|386
Mutations in SLC39A14 disrupt manganese homeostasis and cause childhood-onset parkinsonism–dystonia
|Nature Communications|2016|326